TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.

Rachel N Grisham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.